Skip to main content
. 2016 Feb 22;11(2):e0149534. doi: 10.1371/journal.pone.0149534

Table 4. Clinical response to NACT between the two age groups in patients with stage IB1-IB2 and squamous carcinoma.

IB1-IB2
≤35 >35 Pa
Squamous cell carcinoma
 CR+PR 68 (93.2%) 220 (81.8%) 0.018
 SD+PD 5 (6.8%) 49 (18.2%)

NACT, neoadjuvant chemotherapy; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.

a P value was calculated using the chi-square test.